Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

Why the body can't clear syphilis on its own

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

The immune system does respond to syphilis. It makes antibodies, it mounts a cell-mediated attack, and it pushes the infection down hard enough that symptoms disappear on their own, twice.

And yet without treatment the bacterium survives, sometimes for decades. Here is how a fragile organism that cannot even make its own amino acids manages that.

Related pages: Syphilis

The bottom line

What we know
  • T. pallidum has an outer membrane with very few exposed proteins and no lipopolysaccharide, so there is little for antibodies to grab.
  • One of the few exposed proteins, TprK, varies constantly, so antibodies made against it stop working.
  • It divides roughly once every 30 to 33 hours, far slower than most bacteria.
  • There is no vaccine, and infection gives no reliable protection against being infected again.
What is still open
  • Whether the organism truly hides in protected sites or simply persists at low numbers.
  • Why a vaccine has proven so difficult, and whether one is achievable.

The story, step by step

  1. 1. A bare surface ()
  2. 2. Shape-shifting ()
  3. 3. Slow ()
  4. 4. Quiet corners ()
  5. 5. No vaccine ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

Almost nothing for antibodies to grab

Lab or animal study

What happens

Antibodies work by binding to molecules on a pathogen's surface. Researchers compared T. pallidum's surface with that of ordinary bacteria.

What the research shows

  • It has no lipopolysaccharide, the molecule on most Gram-negative bacteria that sets off an immediate immune alarm.
  • Its outer membrane carries far fewer surface proteins than typical bacteria, by around two orders of magnitude.
  • Most of its proteins sit beneath the outer membrane, out of reach of antibodies.
  • This is why it has sometimes been nicknamed the stealth pathogen.

Why it matters

The immune system can only attack what it can see. This organism has made itself almost invisible without hiding inside cells.

What's still uncertain

  • Counting surface proteins on such a fragile organism is technically difficult, and estimates have been revised over time.

Read more

Next: Shape-shifting

Part 2 of 5

TprK changes constantly, so antibodies go out of date

Lab or animal study

What happens

Of the few proteins exposed on the surface, one called TprK is a main antibody target. Researchers tracked what happens to it during infection.

What the research shows

  • TprK is continuously rebuilt by shuffling in sequences from silent copies elsewhere in the genome.
  • As antibodies accumulate against one version, bacteria carrying different versions survive and multiply.
  • This produces an endless series of variants, and it correlates with the pattern of symptoms disappearing and returning.
  • The same principle appears in gonorrhea and in malaria: it is a common solution to the problem of antibodies.

Why it matters

This is a direct answer to why the immune system cannot finish the job, and a major obstacle to any vaccine.

What's still uncertain

  • How much of the persistence is explained by TprK alone is not settled.

Read more

Next: Slow

Part 3 of 5

Dividing once every day and a half

Lab or animal study

What happens

E. coli divides every 20 minutes or so. T. pallidum takes around 30 to 33 hours.

What the research shows

  • A slow-growing organism presents less material to the immune system at any moment.
  • It also explains the long incubation period, typically about three weeks before a sore appears.
  • And it has a direct treatment consequence: penicillin only kills bacteria while they are building their cell walls, which this organism does rarely.
  • That is why treatment uses a long-acting injection that keeps the drug present for weeks, rather than a short course of pills.

Why it matters

The slowness is both a survival strategy and the reason the treatment is designed the way it is.

What's still uncertain

  • Division rate is measured in animal models and may differ in human tissue.

Read more

Next: Quiet corners

Part 4 of 5

Surviving in places the immune system polices lightly

Review of many studies

What happens

During the latent stage the organism persists for months to decades with no symptoms at all.

What the research shows

  • Small numbers are thought to persist in sites the immune system reaches less effectively, including the nervous system, the eye and the inner ear.
  • Those sites are also where late disease appears, which fits.
  • Latent infection is still detectable by blood test, and still transmissible to a baby in pregnancy.
  • Early latent infection can relapse into a visible secondary stage.

Why it matters

Latent does not mean gone, cured or harmless. It is the stage where people most often assume they are fine.

What's still uncertain

  • Whether these are true sanctuaries or simply low-level persistence is debated, because the organism is so hard to detect in tissue.

Read more

Next: No vaccine

Part 5 of 5

Why there is still no vaccine, and what does work

Review of many studies

What happens

Syphilis has been understood since 1905 and curable since the 1940s, yet there is no vaccine.

What the research shows

  • The surface offers few stable targets, and the main exposed one changes constantly.
  • The organism's resistance to being grown in the laboratory slowed research for a century.
  • Having had syphilis does not reliably protect against catching it again, so reinfection is common.
  • What does work is simple: penicillin cures it at every stage, and it has never developed penicillin resistance, which is remarkable after 80 years.

Why it matters

This is an infection where the old, cheap drug still wins, as long as it is actually given.

What's still uncertain

  • Vaccine research continues and has made progress in animal models.
  • Resistance to the alternative drug azithromycin is widespread, which is why it is no longer recommended.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.